Trials / Unknown
UnknownNCT04682015
Effect of a WeChat Platform-based Management Intervention on Blood Pressure Control
Effect of a WeChat Platform-based Management Intervention on Blood Pressure Control: A Randomized Clinical Trial.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 436 (estimated)
- Sponsor
- First Affiliated Hospital of Wenzhou Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
WeChat is the largest and most popular social media platform in China, In this study, investigators will evaluate the use of management program delivered via WeChat platform in patients with hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | WeChat platform group | Participants in the intervention group will receive educational messages related to hypertension, such as impact of hypertension on cardiovascular system, lifestyle adjustment and side effects of antihypertensive drugs. Participants will be reminded to take their blood pressure regularly and enter the blood pressure readings into the WeChat platform. If participants enter extremely high or low readings, they will be asked to seek medical help from doctors. Participants can also consult doctors online via WeChat platform by text and voice messages, or voice calls. |
Timeline
- Start date
- 2021-02-18
- Primary completion
- 2022-12-31
- Completion
- 2022-12-31
- First posted
- 2020-12-23
- Last updated
- 2021-02-09
Source: ClinicalTrials.gov record NCT04682015. Inclusion in this directory is not an endorsement.